drugset / Trial / NCT00004902
Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of tocladesine in treating patients who have recurrent or refractory multiple myeloma.
Timeline
- Start
- 1998-01
- Primary completion
- 1999-11
- Completion
- 1999-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tocladesine | Small molecule | — | — |